Report of Foreign Issuer (6-k)
September 09 2016 - 2:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer Pursuant
to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of
1934
For the Month of September 2016
Commission File No.: 001-33514
TRANSITION THERAPEUTICS INC.
101 College Street, Suite 220, Toronto,
Ontario, Canada M5G 1L7
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F. Form 20-F
☒
Form 40-F
☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes
☐
No
☒
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes
☐
No
☒
The information furnished herewith is incorporated by reference
into the following Registration Statements:
Registration Statement on
Form S-8 No. 333-157279
The following information is furnished to the Securities and
Exchange Commission as part of this report on Form 6-K:
|
Exhibit No.
|
Document
|
|
99.1
|
Material Change Report filed September 9, 2016.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
TRANSITION THERAPEUTICS INC.
|
|
|
|
|
|
|
|
Date: September 9, 2016
|
By:
|
/s/ Nicole Rusaw
|
|
|
|
Name:
|
Nicole Rusaw
|
|
|
Title:
|
Chief Financial Officer
|
|
|
|
|
Transition Therapeutics - Ordinary Shares (NASDAQ:TTHI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Transition Therapeutics - Ordinary Shares (NASDAQ:TTHI)
Historical Stock Chart
From Apr 2023 to Apr 2024
